O
PFE icon

OppenheimerFunds’s Pfizer PFE Stock Holding History

OppenheimerFunds’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,054
Closed -$7K – 958
2013
Q2 		$7K Buy
+1,054
New +$29.1K ﹤0.01% 909

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds's PFE Position: Q1 2019 in Review

OppenheimerFunds reduced its Pfizer (PFE) stake by 9.9% in Q1 2019, selling an estimated $25.7M and leaving 5,883,786 shares worth $237M. The position accounts for 0.29% of the portfolio, ranked #88.

OppenheimerFunds first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $725M in Q1 2014. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • OppenheimerFunds held 5,883,786 shares of Pfizer worth $237M as of Q1 2019.
  • OppenheimerFunds sold 642,886 Pfizer shares in Q1 2019, an estimated $25.7M.
  • Pfizer made up 0.29% of OppenheimerFunds's portfolio in Q1 2019, its #88 holding.
  • OppenheimerFunds first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Pfizer position peaked at $725M in Q1 2014.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.